This article is also available in:
Русский (Russian) 
Uzbek
In the National Children’s Medical Center in Tashkent, a historic event took place — Uzbekistan’s first successful allogeneic bone marrow transplant was performed to treat children with severe blood diseases. This medical breakthrough opens new possibilities for treating oncological and hematological diseases, giving hope to thousands of children and their families.
The first patients to undergo this complex procedure were six-year-old Murodjon and four-year-old Mubina, who suffered from a severe form of thalassemia. Until recently, such procedures were only available abroad at a high cost, inaccessible to most families. Thanks to the transplant, both children have been completely cured of this life-threatening disease, which is a miracle for their parents and a testament to the effectiveness of new capabilities in domestic medicine.
Allogeneic bone marrow transplants are only performed in 20 countries worldwide and require highly qualified specialists and unique equipment. For Uzbekistan, this operation represents not only a medical breakthrough but also a social achievement, as patients can now receive vital treatment in their own country, without the need to travel abroad and face the challenges of high costs and lengthy waiting times.
The allogeneic bone marrow transplant procedure is crucial for treating a range of diseases, such as blood cancer and various hereditary conditions. This type of transplant allows diseased cells in the blood-forming system to be replaced with healthy donor cells, ensuring full recovery and reducing the risk of relapse. It is essential in these cases to find a compatible donor, and the operation itself requires strict monitoring and specialized care to minimize complications.
Currently, two more children in the National Children’s Medical Center are in need of bone marrow transplants, and approximately 20 such operations are planned by the end of the year. This marks the first step towards establishing a national program for treating severe blood diseases, which will help save more lives and develop the skills of local specialists.
Allogeneic bone marrow transplantation in Uzbekistan opens a new chapter in the fight against severe diseases, showing that the country’s healthcare system is advancing in line with global standards. This event is a source of hope for parents, doctors, and the entire society, ready to support such groundbreaking initiatives and contribute to the improvement of health for future generations.
The article may contain inaccuracies as it is translated by AI. For more details, please refer to the Russian version of the article. If you notice any inaccuracies, you can send corrections via the Telegram bot: Uzvaibik_bot.
